Corrigendum: MicroRNA-608 Promotes Apoptosis in Non-Small Cell Lung Cancer Cells Treated With Doxorubicin Through the Inhibition of TFAP4
- 1School of Basic Medical Sciences, Qingdao University, Qingdao, China
- 2Institute for Translational Medicine, Qingdao University, Qingdao, China
- 3Affiliated Hospital, Qingdao University, Qingdao, China
- 4Department of Gastroenterology, The Seventh Medical Center of PLA General Hospital, Beijing, China
- 5Department of Anesthesiology, The Seventh Medical Center of PLA General Hospital, Beijing, China
by Wang, Y.-F., Ao, X., Liu, Y., Ding, D., Jiao, W.-J., Yu, Z., et al. (2019). Front. Genet. 10:809. doi: 10.3389/fgene.2019.00809
In the original article, there were two mistakes in Figure 5 as published. (1) In Figure 5C, the scale bar didn't match the image. (2) We inadvertently used the apparent duplication in different groups (Con, NC, and Mimic) of Figures 5D and 5E during the figure preparation. We found that the errors were caused by our carelessness in exporting the representative images and compiling these figures. The corrected Figure 5 appears below.
Figure 5. Effect of miR-608 on the proliferation and metastasis of NSCLC cells. Cell proliferation was examined by MTT assay in A549 (A) and HCC4006 (B) cells transfected with miR-608 mimic or var mimic for the indicated times. (C) The effect of miR-608 on metastasis determined by wound-healing assay in A549 cells. Transwell assay results showing the effect of miR-608 on metastasis in A549 cells (D) and HCC4006 (E) cells. miR, microRNA.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: microRNA-608, single nucleotide polymorphisms, apoptosis, transcription factor activating enhancer-binding protein 4, non-small cell lung cancer
Citation: Wang Y-F, Ao X, Liu Y, Ding D, Jiao W-J, Yu Z, Zhai W-X, Dong S-H, He Y-Q, Guo H and Wang J-X (2021) Corrigendum: MicroRNA-608 Promotes Apoptosis in Non-Small Cell Lung Cancer Cells Treated With Doxorubicin Through the Inhibition of TFAP4. Front. Genet. 12:649586. doi: 10.3389/fgene.2021.649586
Received: 05 January 2021; Accepted: 08 March 2021;
Published: 30 March 2021.
Edited and reviewed by: Ihab Younis, Carnegie Mellon University in Qatar, Qatar
Copyright © 2021 Wang, Ao, Liu, Ding, Jiao, Yu, Zhai, Dong, He, Guo and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
†These authors have contributed equally to this work